Daiichi Sankyo Company, Limited has entered into a global development and commercialization agreement with AstraZeneca f...
CPhI Japan closes as a new wave of innovation is rising across the country, driven by structural and regulatory changes....
Gilead Sciences, announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Bikta...
The Global Health Innovative Technology (GHIT) Fund has announced a total of 2.86 billion yen to support 10 partnerships...
Global biotherapeutics leader CSL Behring recently announced that Japan's Ministry of Health, Labour and ...
AbbVie, a research-based global biopharmaceutical company, has announced that the Japanese Ministry of Health, Labour an...
Lupin has announced that YL Biologics Limited (YLB), a joint venture between Lupin’s subsidiary Lupin Atlantis Hol...
Eisai Co., Ltd. has announced that a global Phase III clinical study (Clarity AD/Study 301) of BAN2401, an anti-amyloid ...
Eisai Co., Ltd. announced that a total of seven presentations highlighting the latest data on its Alzheimer's disease/de...
Japanese startup Spiber has recently announced initiation of a joint research and development project using Spiber&rsquo...
Ono Pharmaceutical Co., Ltd., a Japanese pharmaceutical research and development company, and twoXAR, Inc., a US based a...
Blackstone has announced that private equity funds managed by Blackstone have entered into a definitive agreement to acq...
Shimadzu's new Nexera UHPLC series with AI and IoT enhancements sets industry standard for intelligence, efficiency and ...
Chugai Pharmaceutical has announced that Roche received the decision from the European Commission confirming that Hemlib...
Privately held Aprecia Pharmaceuticals, LLC (Aprecia) and CMIC CMO Co., LTD (CMIC CMO) have announced that both com...
FUJIFILM Corporation ("Fujifilm") announced that it has entered into an agreement to acquire Biogen (Denmark) Manufactur...
Eisai Co., Ltd. and Imbrium Therapeutics L.P., a clinical-stage biopharmaceutical company and operating subsidiary of Pu...
US based Oncoceutics, Inc. has announced the outlicense of the rights to the company’s lead compound, ONC201, for ...
Takeda Pharmaceutical Company Limited has announced results from the Phase 3b head-to-head VARSITY study which demonstra...
Akili Interactive, digital medicine company creating prescription treatments for people living with cognitive dysfunctio...
Santen Pharmaceutical Co., Ltd. (Santen) announced on March 8 that as part of its initiatives to increase publ...
Eisai Co., Ltd. has announced that a marketing authorization application has been submitted in Japan for lemborexant, an...
In a study recently published in the European Journal of Pharmacology researchers at Okayama University show h...
Scientists from the Hubrecht Institute, the University of Utrecht, and MIMETAS have successfully grown kidney tubules de...
Australia based AVITA Medical, regenerative medicine company, announced that it has collaborated with COSMOTEC, an M3 Gr...
